These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20424239)

  • 41. Medical decision making in antipsychotic drug choice for schizophrenia.
    Hamann J; Langer B; Leucht S; Busch R; Kissling W
    Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Off-label use of medicine in pediatrics: focus on gastrointestinal diseases.
    Karesh A; Tomaino J; Mulberg AE
    Curr Opin Pediatr; 2013 Oct; 25(5):612-7. PubMed ID: 23995427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Are physicians treating dementia too often with antipsychotics?].
    Hüll M
    MMW Fortschr Med; 2016 May; 158(10):43. PubMed ID: 27221428
    [No Abstract]   [Full Text] [Related]  

  • 44. What the CATIE study means for clinical practice.
    Lieberman JA
    Psychiatr Serv; 2006 Aug; 57(8):1075. PubMed ID: 16870955
    [No Abstract]   [Full Text] [Related]  

  • 45. Prolongation of QTc interval and antipsychotics.
    Agelink MW
    Am J Psychiatry; 2002 Jun; 159(6):1063; author reply 1064. PubMed ID: 12042206
    [No Abstract]   [Full Text] [Related]  

  • 46. [PRESCRIPTION PATTERNS IN THE TREATMENT OF SCHIZOPHRENIA].
    Leiderman EA; Lorenzo L
    Vertex; 2015; 26(119):11-6. PubMed ID: 26323108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. State variation in antipsychotic and benzodiazepine prescribing among hospice beneficiaries in the United States.
    Gerlach LB; Zhang L; Strominger J; Teno J; Bynum JPW; Maust DT
    J Am Geriatr Soc; 2022 Dec; 70(12):3637-3640. PubMed ID: 35942950
    [No Abstract]   [Full Text] [Related]  

  • 48. Prescribing practice and off-label use of psychotropic medications in post-acute brain injury rehabilitation centres: a cross-sectional survey.
    Pisa FE; Cosano G; Giangreco M; Giorgini T; Biasutti E; Barbone F;
    Brain Inj; 2015; 29(4):508-16. PubMed ID: 25549155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antipsychotic polypharmacy in psychiatric practice: is it really doomed?
    Naguy A
    Australas Psychiatry; 2017 Apr; 25(2):200-201. PubMed ID: 28375065
    [No Abstract]   [Full Text] [Related]  

  • 50. ASCP policy statement use of antipsychotic medications in nursing facility residents.
    Consult Pharm; 2011 Aug; 26(8):583-6. PubMed ID: 21840822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A naturalistic study of clinical use of risperidone.
    Binder RL; McNiel DE; Sandberg DA
    Psychiatr Serv; 1998 Apr; 49(4):524-6. PubMed ID: 9550245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Off-label prescribing to children in the United States outpatient setting.
    Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
    Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Reports. The psychopharmacological off-label prescribing in the treatment of children and adolescents with psychiatric disorders].
    Oehler KU; Romanos M; Uzelli-Schwarz O; Dieffenbach R; Vulturius G; Holtmann M; Wewetzer C
    Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):315-7. PubMed ID: 27434690
    [No Abstract]   [Full Text] [Related]  

  • 54. Psychiatrists' attitudes about and informed consent practices for antipsychotics and tardive dyskinesia.
    Schachter DC; Kleinman I
    Psychiatr Serv; 2004 Jun; 55(6):714-7. PubMed ID: 15175474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Off-label prescribing patterns of antidepressants in children and adolescents.
    Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A roadmap to key pharmacologic principles in using antipsychotics: application in clinical practice.
    Preskorn SH
    J Clin Psychiatry; 2009 Apr; 70(4):593-600. PubMed ID: 19403098
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination antipsychotic therapy in clinical practice.
    Tapp A; Wood AE; Secrest L; Erdmann J; Cubberley L; Kilzieh N
    Psychiatr Serv; 2003 Jan; 54(1):55-9. PubMed ID: 12509667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving prescribing practice in psychiatry: the experience of the Prescribing Observatory for Mental Health (POMH-UK).
    Barnes TR; Paton C
    Int Rev Psychiatry; 2011 Aug; 23(4):328-35. PubMed ID: 22026488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Off-label use of medical products.
    National Association Of EMS Physicians
    Prehosp Emerg Care; 2011; 15(3):419. PubMed ID: 21612389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolution of First-generation and Second-generation Antipsychotic Prescribing Patterns in Belgium Between 1997 and 2012: A Population-based Study.
    Morrens M; Destoop M; Cleymans S; VAN DER Spek S; Dom G
    J Psychiatr Pract; 2015 Jul; 21(4):248-58. PubMed ID: 26164050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.